当前位置: 首页 > 期刊 > 《中国药房》 > 20208
编号:13485259
绞股蓝及其活性成分改善糖尿病并发症作用机制的研究进展(5)
http://www.100md.com 2020年4月15日 《中国药房》 20208
     [32] GU XC,XU DC,FU LL,et al. KLF 15 works as an early anti-fibrotic transcriptional regulator in Ang Ⅱ-induced renal fibrosis via down-regulation of CTGF expression[J].Kidney Blood Press Res,2017,42(6):999-1012.

    [33] 黄平,钱康.绞股蓝总皂苷对糖尿病肾病大鼠结缔组织生长因子表达的影响[J].中华中医药学刊,2007,25(11):2235-2238.

    [34] LI SY,HUANG PH,YANG AH,et al. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentia- tion[J]. Kidney Int ......
上一页1 2 3 4 5

您现在查看是摘要页,全文长 3761 字符